Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics' headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia. Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. The potential of oncolytic virotherapy is the ability to treat cancers more effectively and with minimum side-effects.

GenVec, Inc. (NASDAQ: GNVC) GenVec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec’s development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD).

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Jilin Shuangzheng Medical Technology Co., Ltd., established on 2013-03-27, Business scope includes biomedical technology research and development and consulting services,technical consulting,technology transfer;medical instruments,Green facilities,computer,Sales and maintenance of printers and consumables;Medical device production;import and export trade(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Yunnan Yunhe Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines, raw material medicines, Chinese and western medicine preparations, beverages, and health products. The company was founded in 1958 and is headquartered in Honghe, China.

Wuhan Boweide Biotechnology Co., Ltd., established on 2010-09-17, Business scope includes biotechnology R&D and development;Bioengineering Information Consulting;Class I medical device,Biological experiment reagents and consumables,scientific research instrument,Wholesale and retail of laboratory reagents.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Bowei Biotechnology Co., Ltd., established on 2012-12-05, Business scope includes research and development of biological products,engaged in biotechnology,environmental protection,Technology development in the field of bioinformatics,technical consulting,technology transfer,Technical Services,Sales of biological reagents for non-clinical diagnosis,Sanitary materials and medical supplies,Daily and medical rubber products,Manufacturing and sales of glass packaging containers,Manufacture and sales of machinery and equipment,Medical device management,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Nexbio Co., Ltd. provides genomic and proteomic analysis services. It mainly offers a total service of DNA chip analysis from experiment design to result analysis. The company was founded on November 18, 2008 and is headquartered in Daejeon, South Korea.

Tianjin International Biomedical Joint Research Institute Co., Ltd., established on 2010-05-18, Business scope includes scientific and technological research and development and related consulting;Biotechnology R&D and Application;R&D and pilot test of pharmaceutical products,analysis test,Technical Services,information service;Financing Consulting;Business Consulting;House to rent;financial services;Tax agency service;Conference Services;Technology intermediary service;Daily necessities,Wholesale and retail of experimental instruments;laboratory equipment(Does not contain medical devices)research and development,Sales;laboratory materials(Does not contain food,medicine,Hazardous Chemicals and Precursors)promotion of;Wholesale and retail of prepackaged food;Entrusted to provide business services for enterprises.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sansure Biotech, Inc. engages in the research, development, production, and sales of diagnostic reagents and instruments. It also provides third-party medical testing services. The company's products include viral hepatitis, genital infection & genetics, pediatric infection, respiratory infection, nucleic acid blood screening, scientific research, public health, animal disease, nucleic acid extraction, and biochemical series reagents; automatic nucleic acid detection reaction system, and point-of-care testing mobile molecular diagnostic system series instrument; and fluorescence polymerase chain reaction assay software. Sansure Biotech was founded on April 23, 2008 and is headquartered in Changsha, China.

Shenzhen Ai Weidi Biotechnology Co., Ltd., established on 2014-04-10, Business scope includes general business items:Biological product,Technology development of biotechnology products,Operating import and export business;Technical development of diagnostic reagents and raw materials,Technical Services,technology transfer,technical consulting.(None of the above is legal,Administrative regulations,The State Council decides to specify items that require pre-approval and prohibition) ,The licensing program is:Class II,Production of Class III Medical Devices,Sales;Production of diagnostic reagents and raw materials,Sales.